As of 13 May 2026, KMS Medisurgi trades at 74.2× trailing earnings, and the shares are close to their 52-week high. It earns ROCE of 4.8% and ROE of 3.0%, and sales grew 3.4% a year over 3 years while net profit fell 25%. The company has almost no debt. It is a small-cap company with a market cap of ₹44 Cr; the shares rose 5.0% over the past year.
- ₹132.80
- ₹132.80
- ₹132.80
- ₹132.80
- 2K
Health check
- ReturnsModest
+5.0% over the past year.
- Price tagNo peers
P/E 74.2, with no peers to compare.
- GrowthSlow
Sales +3.4%, profit −24.6% a year over 3 years.
- ProfitabilityWeak
ROCE 4.8%.
- Balance sheetSolid
Debt 0.09× equity, interest covered 9.2×.
- Red flags3 to check
Return on equity is low at 3.0%.
Small cap
Defensive
Key metrics
- Market cap
- ₹44 Cr
- Small cap
- P/E
- 74.2
- Price to book
- 5.27
- Book value ₹25.20
- Dividend yield
- 0.04%
- ROE
- 3.0%
- Return on equity
- ROCE
- 4.8%
- Return on capital employed
- Debt to equity
- 0.09
- Debt ₹0.77 Cr
- EPS (TTM)
- ₹1.79
- OPM (TTM)
- 2.5%
- Net margin 2.0%
- Sales growth
- −8.7%
- Latest quarter vs a year ago
- Profit growth
- −96.4%
- Latest quarter vs a year ago
- Price to sales
- 3.59
- EV/EBITDA 47.3
Strengths and risks
Strengths
- Practically debt-free.
- Positive operating cash flow in each of the last 4 years.
Risks to check
- Return on equity is low at 3.0%.
- Quarterly profit down 96.4% on a year ago.
- Quarterly sales down 8.7% on a year ago.
About KMS Medisurgi
KMS Medisurgi Limited engages in the manufacture and marketing of surgical equipment and wound care products in India, Dubai, Vietnam, Australia, Cambodia, Africa, Philippines, Russia, Pakistan, Europe, Bangladesh, and the United States. It provides surgical tapes, such as medi, non-woven microporous surgical, surgical paper, transparent surgical, soft gel surgical, soft silicone, silk, and foam tapes, as well as adhesive tapes U.S.P and non woven…
- Headquarters
- Mumbai
- Employees
- 20
- Sector
- Healthcare
- ISIN
- INE870V01014
- Website
- kmsgroup.in
Price range
- Avg volume (3M)
- 0
- 1-year return
- plus 5.0%
- From 52-week high
- 0.0%
Peers
We couldn’t find listed peers for this company.
Quarterly results
This company doesn’t report these figures in a format we can read yet.
Profit & loss
- Sales CAGR 3Y
- +3.4%
- Profit CAGR 3Y
- −24.6%
- ROE
- 3.0%
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 11 | 13.9 | 13.9 | 12.2 | |
| – | +25.9% | +0.4% | minus 12.4% | |
| 10 | 13.1 | 13 | 11.2 | |
| 1 | 0.8 | 1 | 1 | |
| 9.1% | 5.9% | 6.8% | 8.0% | |
| −0 | 0.1 | 0 | −0 | |
| 0 | 0 | 0.1 | 0.1 | |
| 0.3 | 0.3 | 0.3 | 0.5 | |
| −0 | −0 | – | −0 | |
| 0.7 | 0.6 | 0.6 | 0.3 | |
| 13.0% | 24.9% | 27.9% | 25.7% | |
| 0.6 | 0.5 | 0.4 | 0.2 | |
| – | minus 20.8% | minus 3.1% | minus 44.2% | |
| 1.74 | 1.38 | 1.33 | – |
Forecast
Balance sheet
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 3.3 | 3.3 | 3.3 | 3.3 | |
| 3.9 | 4.4 | 4.8 | 5 | |
| 1 | 0.5 | 0.9 | 0.8 | |
| 1.5 | 2.6 | 1.3 | 1.5 | |
| 9.7 | 10.8 | 10.3 | 10.5 | |
| 1.8 | 2 | 2.8 | 2.9 | |
| – | 0.4 | 1.1 | – | |
| 0 | – | – | – | |
| 0.1 | 0.2 | 0.4 | 0.9 | |
| 7.8 | 8.2 | 6 | 6.7 | |
| 9.7 | 10.8 | 10.3 | 10.5 |
Cash flow
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 0.5 | 1.2 | 0.7 | 1.5 | |
| −0.7 | −0.5 | −1 | −0.6 | |
| −0 | −0.5 | 0.3 | −0.3 | |
| −0.2 | 0.2 | 0 | 0.6 | |
| −0.7 | −0.4 | −0.7 | – | |
| −0.2 | 0.8 | 0.1 | 1.5 | |
| −0 | −0 | −0 | −0 |
Shareholding pattern
This company is listed only on BSE, so there’s no NSE category split. See Major shareholders below for the named holders.
Major shareholders
Filings & events
News
No recent news coverage found.